Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus.

3/60 in the better eye).
Conclusion: People with T2DM presenting at eye clinics in India have high rates of diabetic retinopathy and vision loss. Cataract is a very common occurrence. Advocacy, infrastructure strengthening, and human resource development are the key to address the growing threats of T2DM and eye care in India.
Competing Interests: None -->
References: Indian J Endocrinol Metab. 2016 Apr;20(Suppl 1):S26-32. (PMID: 27144133)
Eur J Ophthalmol. 1993 Jul-Sep;3(3):109-13. (PMID: 8219732)
Ann Ophthalmol. 1989 Feb;21(2):65-6. (PMID: 2469374)
Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3. (PMID: 11190017)
Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2328-33. (PMID: 15980218)
Diabetes Technol Ther. 2010 Oct;12(10):755-61. (PMID: 20818974)
Clin Ophthalmol. 2007 Dec;1(4):475-82. (PMID: 19668525)
BMJ. 2018 Sep 4;362:k1497. (PMID: 30181166)
Br J Ophthalmol. 1999 Aug;83(8):937-40. (PMID: 10413697)
Diabetes Care. 2013 May;36(5):e69. (PMID: 23613609)
Br J Ophthalmol. 2009 Apr;93(4):429-34. (PMID: 19091856)
Diabetes Care. 1998 Sep;21(9):1414-31. (PMID: 9727886)
JAMA. 2007 Aug 22;298(8):902-16. (PMID: 17712074)
Ophthalmic Epidemiol. 1995 Mar;2(1):49-55. (PMID: 7585233)
Anaesthesia. 2015 Dec;70(12):1427-40. (PMID: 26417892)
Br J Anaesth. 2016 Dec;117(6):687-691. (PMID: 27956666)
Indian J Endocrinol Metab. 2016 Apr;20(Suppl 1):S3-S10. (PMID: 27144134)
Ophthalmology. 1983 Jul;90(7):814-20. (PMID: 6194491)
Ophthalmology. 1997 Apr;104(4):712-8. (PMID: 9111268)
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61. (PMID: 19118286)
Ophthalmologica. 2007;221(2):132-41. (PMID: 17380067)
Br J Ophthalmol. 2002 Sep;86(9):1014-8. (PMID: 12185129)
Diabet Med. 2013 Apr;30(4):399-412. (PMID: 22817387)
Diabet Med. 2012 Apr;29(4):420-33. (PMID: 22288687)
Indian J Endocrinol Metab. 2016 Apr;20(Suppl 1):S33-41. (PMID: 27144135)
Ophthalmology. 1996 Aug;103(8):1271-5. (PMID: 8764798)
Am J Epidemiol. 1980 Jun;111(6):769-76. (PMID: 7386451)
Am J Ophthalmol. 1995 Mar;119(3):295-300. (PMID: 7872389)
BMJ. 2012 Nov 30;345:e7885. (PMID: 23204001)
Ophthalmology. 1984 Apr;91(4):315-20. (PMID: 6201791)
Diabetes Care. 2012 Mar;35(3):556-64. (PMID: 22301125)
Diabetes Care. 2008 Sep;31(9):1905-12. (PMID: 18753669)
Lancet Glob Health. 2018 Dec;6(12):e1352-e1362. (PMID: 30219315)
Anesth Analg. 2010 Dec;111(6):1378-87. (PMID: 20889933)
Am J Ophthalmol. 2001 Jan;131(1):61-77. (PMID: 11162981)
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):329-37. (PMID: 25325858)
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596. (PMID: 28601585)
Am J Ophthalmol. 1998 Dec;126(6):782-90. (PMID: 9860001)
Arch Ophthalmol. 2004 Apr;122(4):525-30. (PMID: 15078670)
J Cataract Refract Surg. 1998 Aug;24(8):1099-104. (PMID: 9719970)
JAMA Ophthalmol. 2013 Jul;131(7):870-9. (PMID: 23599174)
Diabetes Care. 2016 Sep;39(9):1643-9. (PMID: 27555623)
Ophthalmology. 2009 Feb;116(2):311-8. (PMID: 19084275)
Lancet Glob Health. 2017 Sep;5(9):e888-e897. (PMID: 28779882)
Contributed Indexing: Keywords: Clinic population; India; diabetes; eye disorders
Entry Date(s): Date Created: 20200116 Date Completed: 20201215 Latest Revision: 20201215
Update Code: 20221213
PubMed Central ID: PMC7001179
DOI: 10.4103/ijo.IJO_33_19
PMID: 31937723
Autor: Das T; Srimati Kanuri Santamma Centre for Vitreoretinal diseases, L V Prasad Eye Institute, Hyderabad, India., Behera UC; Department of Retina and Vitreous, L V Prasad Eye Institute, Bhubaneswar, Odisha, India., Bhattacharjee H; Department of Retina and Vitreous, Sri Sankaradeva Nethralaya, Guwahati, India., Gilbert C; London School of Hygiene and Tropical Medicine, London, UK., Murthy GVS; Indian Institute of Public Health, Public Health Foundation of India, Hyderabad, India., Rajalakshmi R; Department of Ophthalmology, Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India., Pant HB; Indian Institute of Public Health, Public Health Foundation of India, Hyderabad, India., Shukla R; Indian Institute of Public Health, Public Health Foundation of India, Hyderabad, India.
Jazyk: angličtina
Zdroj: Indian journal of ophthalmology [Indian J Ophthalmol] 2020 Feb; Vol. 68 (Suppl 1), pp. S16-S20.
DOI: 10.4103/ijo.IJO_33_19
Abstrakt: Purpose: To document the spectrum of eye diseases in people with type 2 diabetes mellitus (T2DM) reporting to large eye care facilities in India.
Methods: The selection of eye care facilities was based on the zone of the country and robustness of the programs. Only people with known T2DM certified by internist, or taking antidiabetes medications, or referred for diabetes related eye diseases were recruited. The analysis included the demographic characteristics, systemic associations, ocular comorbidities, and visual status.
Results: People (11,182) with T2DM were recruited in 14 eye care facilities (3 in north, 2 in south central, 4 in south, 2 in west, and 3 in east zone); two were government and 12 were non-government facilities. Hypertension was the commonest systemic association (n = 5500; 49.2%). Diabetic retinopathy (n = 3611; 32.3%) and lens opacities (n = 6407; 57.3%) were the common ocular disorders. One-fifth of eyes (n = 2077; 20.4%) were pseudophakic; 547 (5.4%) eyes had glaucoma and 277 (2.5%) eyes had retinal vascular occlusion. At presentation, 4.5% (n = 502) were blind (visual acuity < 3/60 in the better eye) and 9.6% (n = 1077) had moderate to severe visual impairment (visual acuity <6/18-->3/60 in the better eye).
Conclusion: People with T2DM presenting at eye clinics in India have high rates of diabetic retinopathy and vision loss. Cataract is a very common occurrence. Advocacy, infrastructure strengthening, and human resource development are the key to address the growing threats of T2DM and eye care in India.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz: